Ignite Creation Date:
2024-05-06 @ 4:02 AM
Last Modification Date:
2024-10-26 @ 11:42 AM
Study NCT ID:
NCT02435693
Status:
COMPLETED
Last Update Posted:
2015-11-04
First Post:
2015-02-07
Brief Title:
Pharmaceutical Care Program for Type 2 Diabetes Mellitus
Sponsor:
TABREJ MUJAWAR
Organization:
R C Patel Institute of Pharmaceutical Education Research
Study Overview
Official Title:
Evaluation of Pharmaceutical Care Program for Type 2 Diabetes Mellitus in Dhule
Status:
COMPLETED
Status Verified Date:
2015-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
pcp
Brief Summary:
Evaluation of Pharmaceutical Care Program for Type 2 diabetes mellitus in Dhule
Objectives-
1 To evaluate Pharmaceutical care program in Type2 diabetics
2 To evaluate the impacts of Pharmaceutical care on quality of life QOL in patient with Type-2 Diabetes Mellitus
3 To study the prevalence of Type2 diabetics cases in Dhule
4 To study the Assessment of different type of adverse drug reactions ADRs In Type2 diabetics
5 To evaluate the Drug Drug intereaction in Type-2 Diabetes Mellitus
6 To study the impacts of Pharmaceutical care program on glycemic control in patients with Type-2 Diabetes Mellitus
7 To study the Drug utilization pattern in Type-2 Diabetes Mellitus in civil hospital Dhule
8 To compare the efficiency of Pharmaceutical care program and drug in patients with Type-2 Diabetes Mellitus
9 To study the Pharmaco-economic evaluation in Type-2 Diabetes Mellitus patients
10 To increase the patient compliance and positive attitude of patients towards the diabetes disease by counseling
Objectives-
1 To evaluate Pharmaceutical care program in Type2 diabetics
2 To evaluate the impacts of Pharmaceutical care on quality of life QOL in patient with Type-2 Diabetes Mellitus
3 To study the prevalence of Type2 diabetics cases in Dhule
4 To study the Assessment of different type of adverse drug reactions ADRs In Type2 diabetics
5 To evaluate the Drug Drug intereaction in Type-2 Diabetes Mellitus
6 To study the impacts of Pharmaceutical care program on glycemic control in patients with Type-2 Diabetes Mellitus
7 To study the Drug utilization pattern in Type-2 Diabetes Mellitus in civil hospital Dhule
8 To compare the efficiency of Pharmaceutical care program and drug in patients with Type-2 Diabetes Mellitus
9 To study the Pharmaco-economic evaluation in Type-2 Diabetes Mellitus patients
10 To increase the patient compliance and positive attitude of patients towards the diabetes disease by counseling
Detailed Description:
To evaluate the impacts of Pharmaceutical care on quality of life QOL in patient with Type-2 Diabetes Mellitus
To study the prevalence of Type2 diabetics cases in Dhule To study the Assessment of different type of adverse drug reactions ADRs In Type2 diabetics
To evaluate the Drug Drug intereaction in Type-2 Diabetes Mellitus
To study the prevalence of Type2 diabetics cases in Dhule To study the Assessment of different type of adverse drug reactions ADRs In Type2 diabetics
To evaluate the Drug Drug intereaction in Type-2 Diabetes Mellitus
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None